Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Asian J Androl ; 8(6): 685-92, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16855765

RESUMO

AIM: To assess the efficacy and safety of tadalafil in comparison to a placebo, when taken on demand for 12 weeks by East/Southeast Asian men with erectile dysfunction (ED). METHODS: This multicenter, randomized, double-blind, parallel group, placebo-controlled study was conducted at 17 centers across East and Southeast Asia between August 2002 and February 2003. Men more than 18 years of age with mild to severe ED of various etiologies were randomized to receive a placebo or 20 mg of tadalafil taken as needed (maximum once daily). Efficacy assessments included the International Index of Erectile Function, the Sexual Encounter Profile diary and Global Assessment Questions. RESULTS: Tadalafil significantly improved erectile function as compared to the placebo (P < 0.001). At the endpoint, the patients receiving 20 mg of tadalafil reported a greater mean per patient percentage of successful intercourse attempts (Sexual Encounter Profile question 3: 70.9% compared to 33.5% in the placebo) and a greater proportion of improved erections (Global Assessment Question: 86.2% compared to 30.1%). Most (= or < 3%) treatment emergent adverse events were mild or moderate. The most common treatment emergent adverse events were headache, back pain, dizziness and dyspepsia. CONCLUSION: Tadalafil was an effective and well-tolerated treatment for ED in East and Southeast Asian men.


Assuntos
Carbolinas/uso terapêutico , Disfunção Erétil/tratamento farmacológico , Inibidores de Fosfodiesterase/uso terapêutico , Adolescente , Adulto , Idoso , Sudeste Asiático , Carbolinas/efeitos adversos , China , Método Duplo-Cego , Humanos , Masculino , Pessoa de Meia-Idade , Inibidores de Fosfodiesterase/efeitos adversos , Tadalafila , Resultado do Tratamento
2.
Artigo em Inglês | WPRIM (Pacífico Ocidental) | ID: wpr-732483

RESUMO

From July 1987 to May 1990, a total of 13 simultaneous bilateral percutaneous nephrolithotripsies (PCNL) were performed in two medical institutions for bilateral proximal ureteral stones, bilateral pelvolithiasis and nephrolithiasis, and bilateral staghorn calculi. No major complications occurred. It appears that simultaneous bilateral PCNL has several advantages including reasonable operative time, safety of the procedure and cost effectiveness. Greater applications of this procedures is encouraged. (Author)


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Adulto , Cálculos Urinários , Nefrolitíase , Cálculos Coraliformes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...